Ianthus Capital Holdings IAN.CN · CAD
Health Care · Canadian Securities Exchange · 🇨🇦 Canada
0.01
—
Close of 4 Nov 2026, in CAD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Ianthus Capital Holdings
Its shares trade on Canadian Securities Exchange under the ticker IAN.CN. It has been listed since 7 September 2016. In the fiscal year to 31 December 2025, it reported revenue of $144.0m and a net loss of $40.2m. At that date it held total assets of $256.0m and shareholders' equity of −$103.0m.
iAnthus Capital Holdings, Inc. engages in the provision of financing licensed cannabis cultivators, processors, and dispensaries. The company is headquartered in New York City, New York. The company went IPO on 2016-09-07. The firm is also a developer, producer and distributor of branded cannabis and cannabidiol (CBD) products in the United States. Through its subsidiaries, the Company owns and/or operates 35 dispensaries and 11 cultivation and/or processing facilities in nine United States. The Company’s two geographical segments are Eastern Region and Western Region. The Eastern Region includes the Company’s operations in Florida, Maryland, Massachusetts, New York, New Jersey, and Vermont. The Western Region includes the Company’s operations in Arizona and Nevada as well as its assets and investments in Colorado. Its CBD products include topical creams, tinctures and sprays and products designed for beauty and skincare (such as lotions, creams, haircare products, lip balms and bath bombs).
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 7 Sept 2016
- Website
- ianthus.com ↗
Leadership
Pay as last reported
- Mr. Richard ProudChief Executive Officer, Director, since 2023$1.0m
- Mr. Justin VuChief Financial Officer$283,000
- Mr. Alexander ShoghiDirector$227,500
- Mr. Scott CohenIndependent Director$235,000
- Mr. Kenneth GilbertIndependent Director$215,000
- Ms. Michelle Mathews- SpradlinIndependent Director$305,000
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- iAnthus Capital Holdings Inc. operates 35 dispensaries across nine United States.
- The company owns and/or operates 11 cultivation and/or processing facilities in the United States.
- iAnthus Capital Holdings Inc. provides financing to licensed cannabis cultivators, processors, and dispensaries.
Weaknesses
- The company's operations are restricted to the United States.
- The firm is limited to two geographical segments, the Eastern Region and Western Region.
- The company's CBD product line is confined to topical creams, tinctures, sprays, and beauty items.
Opportunities
- The company can expand its assets and investments in Colorado within the Western Region.
- iAnthus Capital Holdings Inc. can grow its presence in Florida, Maryland, Massachusetts, New York, New Jersey, and Vermont.
- The firm can increase distribution of branded cannabis and cannabidiol products in the United States.
Threats
- The company faces regulatory risks associated with the pharmaceutical and cannabis sectors.
- Competition exists among licensed cannabis cultivators, processors, and dispensaries in the United States.
- The company's financial performance depends on the stability of its 35 dispensaries and 11 facilities.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.